Greenland Mines Ltd (NASDAQ: GRML) has announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company. The company plans to spin off its biotechnology division in the fourth quarter of 2026, a move that underscores its strategic shift toward mining assets. The spin-off will allow the biotech segment, including Klotho’s KLTO-202 primary indication for ALS, to operate independently while Greenland Mines concentrates on its mineral projects.
The company has also achieved full compliance with Nasdaq listing requirements following formal approval of its application related to the March 2026 transaction. This resolves prior deficiencies and ensures the company's continued listing on the exchange. The approval is a significant step for Greenland Mines as it seeks to attract investment and advance its development projects.
Greenland Mines completed the acquisition of the Sarfartoq project on Sept. 1, following approval by the Government of Greenland. The project, located in southwest Greenland, is a key asset for the company's neodymium-praseodymium (NdPr) rare earths production ambitions. An independent S-K 1300 Initial Assessment for the ST1 deposit estimated a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%. These figures highlight the significant economic potential of the project.
Planned annual NdPr oxide production from ST1 would equal approximately 34% of current NdPr oxide refining outside China based on 2025 consumption levels, during each of the project's nine scheduled operating years. This positions Greenland Mines as a potential major player in the rare earths supply chain, which is critical for technologies such as electric vehicles and wind turbines. The company's focus on NdPr is timely, given the global push to diversify supply chains away from China.
In addition to the Sarfartoq project, Greenland Mines is advancing its Skaergaard palladium-gold-platinum project in southeast Greenland. The company is also reshaping its board, with Riad El-Dada and Dr. Shalom Hirschman stepping down and capital markets veteran Jason Hawkins joining. These changes are aimed at strengthening the company's leadership as it moves forward with its mining projects.
The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities. This aligns with its broader North Atlantic Critical Metals Corridor vision, which links Greenland resources with allied downstream jurisdictions and industrial infrastructure. The implications of these developments are significant for investors and the critical minerals sector, as Greenland Mines positions itself to become a key supplier of essential materials for the green energy transition.
